Viewing Study NCT03409627

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:27 AM
Study NCT ID: NCT03409627
Status: COMPLETED
Last Update Posted: 2020-12-04
First Post: 2017-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Novel INXN-4001 Triple Effector Plasmid in Heart Failure
Sponsor: Triple-Gene, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure View
None Cardiovascular Diseases View
None Heart-Assist Device View
Keywords:

Keywords

Keyword Brief Keyword Text View
None retrograde coronary sinus infusion View
None DNA View
None non-viral View
None triple effector plasmid View
None gene therapy View
None regenerative medicine View
None non-stem cell View